New Jersey resident Neurologist, Dr. Eric Cohen was recently named one of the area's Top Doctors by New Jersey Monthly magazine. In addition to this recognition in 2012, Dr. Eric Cohen was similarly recognized by the same publication in 2009, 2010,2011.
Dr. Eric Cohen is based in New Jersey, where he splits his time between his patients at a private practice clinic and those at a regional hospital. Dr. Eric Cohen calls the private practice Summit Medical Group of Berkeley, New Jersey, his primary offices. Dr. Eric Cohen also lends his considerable expertise to Overlook Hospital of Summit, New Jersey, as an on-call Attending Neurologist. In addition to his direct work with patients, Dr. Eric Cohen also serves as an educator as Assistant Clinical Professor of Neurology at Mt. Sinai Medical Center. Dr. Eric Cohen first headed toward becoming a Neurologist in 1996, when he earned his B.A. in Biology from the Bloomington based Indiana University, and then obtained his Doctor of Osteopathic Medicine in 2001 from the New York College of Osteopathic Medicine. Following his Internship and Residency, both of which Dr. Eric Cohen accomplished in New York City, Dr. Eric Cohen was granted his board certification in Neurology by the American Board of Psychiatry and Neurology. In addition, Dr. Eric Cohen is a member of several professional organizations, including the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Osteopathic Association, the American Academy of Osteopathy and the Cranial Academy. Dr. Eric Cohen has several professional interests, primarily in the fields of neurology, epilepsy and biodynamic osteopathy. Dr Cohen has spent a large amount of time studying and continual taking courses in osteopathy. In his practice, Dr. Eric Cohen helps patients suffering from conditions such as sleep disorders, movement disorders, headaches, dementia, and multiple sclerosis. As a research physician, Dr. Eric Cohen plans to conduct clinical trials with the aim of developing new neurological treatments.